1
Luyendijk, Marianne, Blommestein, Hedwig, Uyl-de Groot, Carin, Siesling, Sabine, Jager, Agnes
Veröffentlicht in: Luyendijk , M , Blommestein , H , Uyl-de Groot , C , Siesling , S & Jager , A 2023 , ' Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands ' , JAMA network open , vol. 6 , no. 2 , pp. e2256170 . https://doi.org/10.1001/jamanetworkopen.2022.56170;
2023
Veröffentlicht in: Luyendijk , M , Blommestein , H , Uyl-de Groot , C , Siesling , S & Jager , A 2023 , ' Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands ' , JAMA network open , vol. 6 , no. 2 , pp. e2256170 . https://doi.org/10.1001/jamanetworkopen.2022.56170;
2023
2
3
Rabbe, Stefan, Möllenkamp, Meilin, Pongiglione, Benedetta, Blommestein, Hedwig, Wetzelaer, Pim, Heine, Renaud, Schreyögg, Jonas
Veröffentlicht in: Rabbe , S , Möllenkamp , M , Pongiglione , B , Blommestein , H , Wetzelaer , P , Heine , R & Schreyögg , J 2022 , ' Variation in the utilization of medical devices across Germany, Italy, and the Netherlands : A multilevel approach ' , Health Economics (United Kingdom) , vol. 31 , no. S1 , pp. 135-156 . https://doi.org/10.1002/hec.4492;
2022
Veröffentlicht in: Rabbe , S , Möllenkamp , M , Pongiglione , B , Blommestein , H , Wetzelaer , P , Heine , R & Schreyögg , J 2022 , ' Variation in the utilization of medical devices across Germany, Italy, and the Netherlands : A multilevel approach ' , Health Economics (United Kingdom) , vol. 31 , no. S1 , pp. 135-156 . https://doi.org/10.1002/hec.4492;
2022
4
5
Bennink, Christine, Brink, Mirian, Duijts, Saskia F.A., Scheurer, Hans, Sonneveld, Pieter, Blommestein, Hedwig M.
Veröffentlicht in: Bennink , C , Brink , M , Duijts , S F A , Scheurer , H , Sonneveld , P & Blommestein , H M 2024 , ' Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands ' , Clinical Lymphoma, Myeloma and Leukemia , vol. 24 , no. 9 , pp. 604-610 . https://doi.org/10.1016/j.clml.2024.04.004;
2024
Veröffentlicht in: Bennink , C , Brink , M , Duijts , S F A , Scheurer , H , Sonneveld , P & Blommestein , H M 2024 , ' Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands ' , Clinical Lymphoma, Myeloma and Leukemia , vol. 24 , no. 9 , pp. 604-610 . https://doi.org/10.1016/j.clml.2024.04.004;
2024
6
Chen, Yi Hsuan, Blommestein, Hedwig M., Klazenga, Reinder, Uyl-de Groot, Carin, van Vulpen, Marco
Veröffentlicht in: Chen , Y H , Blommestein , H M , Klazenga , R , Uyl-de Groot , C & van Vulpen , M 2023 , ' Costs of Newly Funded Proton Therapy Using Time-Driven Activity-Based Costing in The Netherlands ' , Cancers , vol. 15 , no. 2 , 516 . https://doi.org/10.3390/cancers15020516;
2023
Veröffentlicht in: Chen , Y H , Blommestein , H M , Klazenga , R , Uyl-de Groot , C & van Vulpen , M 2023 , ' Costs of Newly Funded Proton Therapy Using Time-Driven Activity-Based Costing in The Netherlands ' , Cancers , vol. 15 , no. 2 , 516 . https://doi.org/10.3390/cancers15020516;
2023
7
8
Blommestein, Hedwig, de Groot, Saskia, Aarts, MJ, Vemer, P (Pepijn), de Vries, R, Abeelen, AFM, Posthuma, EFM, Uyl - de Groot, Carin
Veröffentlicht in: Blommestein , H , de Groot , S , Aarts , MJ , Vemer , P , de Vries , R , Abeelen , AFM , Posthuma , EFM & Uyl - de Groot , C 2016 , ' Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands ' , Leukemia Research , vol. 50 , pp. 37-45 . https://doi.org/10.1016/j.leukres.2016.09.005;
2016
Veröffentlicht in: Blommestein , H , de Groot , S , Aarts , MJ , Vemer , P , de Vries , R , Abeelen , AFM , Posthuma , EFM & Uyl - de Groot , C 2016 , ' Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands ' , Leukemia Research , vol. 50 , pp. 37-45 . https://doi.org/10.1016/j.leukres.2016.09.005;
2016
9
Verelst, Silvia, Blommestein, Hedwig, de Groot, Saskia, Gonzalez-McQuire, S, DeCosta, L, de Raad, JB, Uyl - de Groot, Carin, Sonneveld, Pieter
Veröffentlicht in: Verelst , S , Blommestein , H , de Groot , S , Gonzalez-McQuire , S , DeCosta , L , de Raad , JB , Uyl - de Groot , C & Sonneveld , P 2018 , ' Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS) ' , HemaSphere , vol. 2 , no. 4 . https://doi.org/10.1097/HS9.0000000000000045;
2018
Veröffentlicht in: Verelst , S , Blommestein , H , de Groot , S , Gonzalez-McQuire , S , DeCosta , L , de Raad , JB , Uyl - de Groot , C & Sonneveld , P 2018 , ' Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS) ' , HemaSphere , vol. 2 , no. 4 . https://doi.org/10.1097/HS9.0000000000000045;
2018
10